Secondary Prevention in Cardiovascular Medicine: State of the Art and New Frontiers

Dear Colleagues,

Cardiovascular diseases result in millions of deaths around the globe annually, most of which are avoidable if identified early. Preventive healthcare has a major role in the fight against cardiovascular diseases. This Special Issue presents a collection of papers concerning the state of the art and new frontiers in secondary prevention in cardiovascular medicine. Firstly, it discusses the role of risk stratification after an acute event, the impact of associate clinical conditions and the challenge of adherence and mental health care in cardiac patients. Secondly, it analyzes the role of interventions in optimizing lifestyle and the management of different risk factors associated with cardiovascular diseases. Finally, it discusses the role of new technologies, cardiac rehabilitation and epigenetics in cardiovascular secondary prevention.

Management of cardiovascular risk factors is suboptimal in the context of secondary prevention, despite the high risk of cardiovascular events and the absolute benefit of effective risk factor treatment. This is because secondary cardiovascular prevention pathways are complex and difficult to organize, including the need for diagnostic and therapeutic interventions from a multidisciplinary team in a patient-centered integrated model. The aim of this Special Issue is to increase the sensitivity about this fundamental area of cardiovascular medicine.

Dr. Roberto F. E. Pedretti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cardiovascular disease
• prevention
• secondary prevention 
• risk stratification
• adherence 
• smoking
• blood pressure
• lipids
• diabetes mellitus 
• digital health 
• cardiac rehabilitation